The selection of commercially viable drug candidates and advancing their development
toward worldwide markets is a complex and challenging task that requires people with a broad
range of different qualifications and drug development know-how.

Paulo Lacativa

CEOScientific Development Director

Back to team

Paulo is a medical doctor with an MS and Ph.D. in Endocrinology from the Federal University of Rio de Janeiro (URFJ). Besides his position as Professor of Internal Medicine at UERJ, Paulo served from 2004-2014 as the Clinical Manager and Chief of the Quality Department at the Center for Clinical and Basic Research (CCBR), a dedicated clinical trial research center. He participated in more than 60 clinical trials in various areas like cardiovascular diseases, diabetes mellitus, dyslipidemias and obesity, osteoporosis, rheumatoid arthritis, pain, Alzheimer’s disease, COPD and asthma and women’s health. Paulo is the founder and director of the Clinical Trials Designers, a group acting as a steering committee in Rio de Janeiro. He is Data Safety Monitoring Board fellow (first class) from the Multi-Regional Clinical Trial Center (MRCT) group, from the Harvard Global Health Institute. Paulo joined the Biozeus team in 2014.